Viewing Study NCT03404960


Ignite Creation Date: 2025-12-25 @ 2:08 AM
Ignite Modification Date: 2025-12-26 @ 12:34 AM
Study NCT ID: NCT03404960
Status: COMPLETED
Last Update Posted: 2025-10-10
First Post: 2017-12-19
Is NOT Gene Therapy: False
Has Adverse Events: True

Brief Title: Niraparib + Ipilimumab or Nivolumab in Progression Free Pancreatic Adenocarcinoma After Platinum-Based Chemotherapy
Sponsor: University of Pennsylvania
Organization:

Key Dates - Follows AllAPIJSON File Order

Start Date: 2018-01-31
Start Date Type: ACTUAL
Primary Completion Date: 2022-04-05
Primary Completion Date Type: ACTUAL
Completion Date: 2024-10-09
Completion Date Type: ACTUAL
First Submit Date: 2017-12-19
First Submit QC Date: None
Study First Post Date: 2018-01-19
Study First Post Date Type: ACTUAL
Results First Submit Date: 2023-05-09
Results First Submit QC Date: None
Results First Post Date: 2023-07-03
Results First Post Date Type: ACTUAL
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: 2023-07-03
Disp First Post Date Type: ACTUAL
Last Update Submit Date: 2025-09-30
Last Update Post Date: 2025-10-10
Last Update Post Date Type: ESTIMATED